Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapy-Reference-Cited by-同舟云学术

Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapy

Published:2020-05-29 Issue:5 Volume:10 Page:90-103
ISSN:2220-3230
Container-title:World Journal of Transplantation
language:
Short-container-title:WJT

Author:

Salvadori Maurizio,Tsalouchos Aris

Publisher

Baishideng Publishing Group Inc.

Reference80 articles.

1. Casati C, Menegotto A, Querques ML, Ravera F, Colussi G. [Immunosuppression in kidney transplantation: a way between efficacy and toxicity]. G Ital Nefrol 2017; 34: 29-39

2. A New Initiative on Precision Medicine

3. Pharmacogenomics: Challenges and Opportunities

4. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010; 363: 166-176

5. Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Allograft Longevity: Leveraging Omics Technologies to Improve Heart Transplant Outcomes;Current Heart Failure Reports;2023-11-15

2. CYP3A5 and POR gene polymorphisms as predictors of infection and graft rejection in post-liver transplant patients treated with tacrolimus - a cohort study;2023-10-09

3. The Value of Pharmacogenomics for White and Indigenous Americans after Kidney Transplantation;Pharmacy;2023-08-08

4. Pancreas Rejection in the Artificial Intelligence Era: New Tool for Signal Patients at Risk;Journal of Personalized Medicine;2023-06-29

5. Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens;Best Practice & Research Clinical Haematology;2023-06